Association of menopausal status with metabolic syndrome and depression: CLSA baseline findings
Channel: Canadian Longitudinal Study on Aging (CLSA/ÉLCV)
Date: 25/09/2020

This webinar will showcase two studies investigating menopause using cross-sectional baseline data collected from the Canadian Longitudinal Study on Aging (CLSA). The first study, led by Dr. Alison Shea of McMaster University, explored the association between menopause status, hormone therapy (HT) use and the presence of depression among 13,216 women aged 45-64 in the CLSA. The second study, led by Dr. Marie Christakis of the University of Toronto, evaluated whether menopause is an independent risk factor for the development of metabolic syndrome (MetS) or its components, including hypertension, central obesity, dyslipidemia (abnormal levels of lipids in the blood) or elevated glycated hemoglobin. This study conducted an analysis of 12,611 of women aged 45-85 in the CLSA Comprehensive Cohort.

Stay connected with the CLSA:

Web: http://clsa-elcv.ca 
Facebook EN: https://www.facebook.com/CanadianLongitudinalStudyonAging
Facebook FR: https://www.facebook.com/EtudeLongitudinaleCanadienneSurLeVieillissement
Twitter: http://twitter.com/clsa_elcv
Instagram: http://www.instagram.com/clsa_elcv